Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2013, Article ID 852418, 9 pages
http://dx.doi.org/10.1155/2013/852418
Review Article

Loss and Dysregulation of Th17 Cells during HIV Infection

Department of Microbiology & Immunology, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA

Received 1 March 2013; Accepted 10 May 2013

Academic Editor: Samuel Huber

Copyright © 2013 Sandra L. Bixler and Joseph J. Mattapallil. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Grimbacher, S. M. Holland, J. I. Gallin et al., “Hyper-IgE syndrome with recurrent infections—an autosomal dominant multisystem disorder,” New England Journal of Medicine, vol. 340, no. 9, pp. 692–702, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. J. D. Milner, J. M. Brenchley, A. Laurence et al., “Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome,” Nature, vol. 452, no. 7188, pp. 773–776, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. K. Atarashi, J. Nishimura, T. Shima et al., “ATP drives lamina propria TH17 cell differentiation,” Nature, vol. 455, no. 7214, pp. 808–812, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. J. M. Brenchley, M. Paiardini, K. S. Knox et al., “Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections,” Blood, vol. 112, no. 7, pp. 2826–2835, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. I. I. Ivanov, R. D. L. Frutos, N. Manel et al., “Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine,” Cell Host and Microbe, vol. 4, no. 4, pp. 337–349, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Mucida and S. Salek-Ardakani, “Regulation of TH17 cells in the mucosal surfaces,” Journal of Allergy and Clinical Immunology, vol. 123, no. 5, pp. 997–1003, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Raffatellu, R. L. Santos, D. E. Verhoeven et al., “Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut,” Nature Medicine, vol. 14, no. 4, pp. 421–428, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. L. E. Harrington, R. D. Hatton, P. R. Mangan et al., “Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages,” Nature Immunology, vol. 6, no. 11, pp. 1123–1132, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Park, Z. Li, X. O. Yang et al., “A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17,” Nature Immunology, vol. 6, no. 11, pp. 1133–1141, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Steinman, “A brief history of TH17, the first major revision in the T H1/TH2 hypothesis of T cell-mediated tissue damage,” Nature Medicine, vol. 13, no. 2, pp. 139–145, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Bengsch, B. Seigel, T. Flecken, J. Wolanski, H. E. Blum, and R. Thimme, “Human Th17 cells express high levels of enzymatically active dipeptidylpeptidase IV (CD26),” Journal of Immunology, vol. 188, pp. 5438–5447, 2012. View at Google Scholar
  12. S. Romagnani, E. Maggi, F. Liotta, L. Cosmi, and F. Annunziato, “Properties and origin of human Th17 cells,” Molecular Immunology, vol. 47, no. 1, pp. 3–7, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Annunziato, L. Cosmi, F. Liotta, E. Maggi, and S. Romagnani, “Defining the human T helper 17 cell phenotype,” Trends in Immunology, vol. 33, pp. 505–512, 2012. View at Google Scholar
  14. L. Maggi, V. Santarlasci, M. Capone et al., “CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC,” European Journal of Immunology, vol. 40, no. 8, pp. 2174–2181, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Nistala, S. Adams, H. Cambrook et al., “Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 33, pp. 14751–14756, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. E. Bettelli, Y. Carrier, W. Gao et al., “Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells,” Nature, vol. 441, no. 7090, pp. 235–238, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. C. L. Langrish, Y. Chen, W. M. Blumenschein et al., “IL-23 drives a pathogenic T cell population that induces autoimmune inflammation,” Journal of Experimental Medicine, vol. 201, no. 2, pp. 233–240, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. I. A. Ferber, S. Brocke, C. Taylor-Edwards et al., “Mice with a disrupted IFN-γ gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE),” Journal of Immunology, vol. 156, no. 1, pp. 5–7, 1996. View at Google Scholar · View at Scopus
  19. B. Gran, G. X. Zhang, S. Yu et al., “IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination,” Journal of Immunology, vol. 169, no. 12, pp. 7104–7110, 2002. View at Google Scholar · View at Scopus
  20. G. X. Zhang, B. Gran, S. Yu et al., “Induction of experimental autoimmune encephalomyelitis in IL-12 receptor-β2-deficient mice: IL-12 responsiveness is not required in the pathogenesis of inflammatory demyelination in the central nervous system,” Journal of Immunology, vol. 170, no. 4, pp. 2153–2160, 2003. View at Google Scholar · View at Scopus
  21. M. Laan, Z. H. Cui, H. Hoshino et al., “Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways,” Journal of Immunology, vol. 162, no. 4, pp. 2347–2352, 1999. View at Google Scholar · View at Scopus
  22. M. Miyamoto, O. Prause, M. Sjöstrand, M. Laan, J. Lötvall, and A. Lindén, “Endogenous IL-17 as a mediator of neutrophil recruitment caused by endotoxin exposure in mouse airways,” Journal of Immunology, vol. 170, no. 9, pp. 4665–4672, 2003. View at Google Scholar · View at Scopus
  23. T. Kinugasa, T. Sakaguchi, X. Gu, and H. Reinecker, “Claudins regulate the intestinal barrier in response to immune mediators,” Gastroenterology, vol. 118, no. 6, pp. 1001–1011, 2000. View at Google Scholar · View at Scopus
  24. D. J. Cua and C. M. Tato, “Innate IL-17-producing cells: the sentinels of the immune system,” Nature Reviews Immunology, vol. 10, no. 7, pp. 479–489, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Y. Kao, Y. Chen, P. Thai et al., “IL-17 markedly up-regulates β-defensin-2 expression in human airway epithelium via JAK and NF-κB signaling pathways,” Journal of Immunology, vol. 173, no. 5, pp. 3482–3491, 2004. View at Google Scholar · View at Scopus
  26. S. C. Liang, X. Y. Tan, D. P. Luxenberg et al., “Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides,” Journal of Experimental Medicine, vol. 203, no. 10, pp. 2271–2279, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. S. J. Aujla, P. J. Dubin, and J. K. Kolls, “Th17 cells and mucosal host defense,” Seminars in Immunology, vol. 19, no. 6, pp. 377–382, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Dong, “TH17 cells in development: an updated view of their molecular identity and genetic programming,” Nature Reviews Immunology, vol. 8, no. 5, pp. 337–348, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. G. Pickert, C. Neufert, M. Leppkes et al., “STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing,” Journal of Experimental Medicine, vol. 206, no. 7, pp. 1465–1472, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. E. V. Acosta-Rodriguez, G. Napolitani, A. Lanzavecchia, and F. Sallusto, “Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells,” Nature Immunology, vol. 8, no. 9, pp. 942–949, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. F. Annunziato, L. Cosmi, V. Santarlasci et al., “Phenotypic and functional features of human Th17 cells,” Journal of Experimental Medicine, vol. 204, no. 8, pp. 1849–1861, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Kader, S. Bixler, M. Roederer, R. Veazey, and J. J. Mattapallil, “CD4 T cell subsets in the mucosa are CD28+Ki-67-HLA-DR-CD69+ but show differential infection based on α4β7 receptor expression during acute SIV infection,” Journal of Medical Primatology, vol. 38, supplement 1, pp. 24–31, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Mavigner, M. Cazabat, M. Dubois et al., “Altered CD4+ T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individuals,” Journal of Clinical Investigation, vol. 122, pp. 62–69, 2012. View at Publisher · View at Google Scholar
  34. K. Oboki, T. Ohno, H. Saito, and S. Nakae, “Th17 and allergy,” Allergology International, vol. 57, no. 2, pp. 121–134, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Li, X. Chen, Z. Liu, Q. Yue, and H. Liu, “Expression of Th17 cytokines in skin lesions of patients with psoriasis,” Journal of Huazhong University of Science and Technology, vol. 27, no. 3, pp. 330–332, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. M. A. Lowes, T. Kikuchi, J. Fuentes-Duculan et al., “Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells,” Journal of Investigative Dermatology, vol. 128, no. 5, pp. 1207–1211, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Fujino, A. Andoh, S. Bamba et al., “Increased expression of interleukin 17 in inflammatory bowel disease,” Gut, vol. 52, no. 1, pp. 65–70, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Kobayashi, S. Okamoto, T. Hisamatsu et al., “IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease,” Gut, vol. 57, no. 12, pp. 1682–1689, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Huber, S. Heink, A. Pagenstecher et al., “IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitis,” Journal of Clinical Investigation, vol. 123, pp. 247–260, 2013. View at Google Scholar
  40. A. Saxena, S. Desbois, N. Carrie, M. Lawand, L. T. Mars, and R. S. Liblau, “Tc17 CD8+ T cells potentiate Th1-mediated autoimmune diabetes in a mouse model,” Journal of Immunology, vol. 189, pp. 3140–3149, 2012. View at Publisher · View at Google Scholar
  41. S. G. Nanjappa, E. Heninger, M. Wuthrich, D. J. Gasper, and B. S. Klein, “Tc17 cells mediate vaccine immunity against lethal fungal pneumonia in immune deficient hosts lacking CD4+ T cells,” PLoS Pathogens, vol. 8, Article ID e1002771, 2012. View at Google Scholar
  42. J. M. Brenchley, T. W. Schacker, L. E. Ruff et al., “CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract,” Journal of Experimental Medicine, vol. 200, no. 6, pp. 749–759, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. M. Guadalupe, E. Reay, S. Sankaran et al., “Severe CD4+ T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy,” Journal of Virology, vol. 77, no. 21, pp. 11708–11717, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Kader, S. Bixler, M. Piatak, J. Lifson, and J. J. Mattapallil, “Anti-retroviral therapy fails to restore the severe Th-17: Tc-17 imbalance observed in peripheral blood during simian immunodeficiency virus infection,” Journal of Medical Primatology, vol. 38, no. 1, pp. 32–38, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Kader, W. M. Hassan, M. Eberly et al., “Antiretroviral therapy prior to acute viral replication preserves CD4 T cells in the periphery but not in rectal mucosa during acute simian immunodeficiency virus infection,” Journal of Virology, vol. 82, no. 22, pp. 11467–11471, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Kader, X. Wang, M. Piatak et al., “α4+β7hiCD4+ memory T cells harbor most Th-17 cells and are preferentially infected during acute SIV infection,” Mucosal Immunology, vol. 2, no. 5, pp. 439–449, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. Q. Li, L. Dua, J. D. Estes et al., “Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells,” Nature, vol. 434, no. 7037, pp. 1148–1152, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. J. J. Mattapallil, D. C. Douek, B. Hill, Y. Nishimura, M. Martin, and M. Roederer, “Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection,” Nature, vol. 434, no. 7037, pp. 1093–1097, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Mehandru, M. A. Poles, K. Tenner-Racz et al., “Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract,” Journal of Experimental Medicine, vol. 200, no. 6, pp. 761–770, 2004. View at Publisher · View at Google Scholar · View at Scopus
  50. S. Mehandru, M. A. Poles, K. Tenner-Racz et al., “Lack of mucosal immune reconstitution during prolonged treatment of acute and early HIV-1 infection,” PLoS Medicine, vol. 3, no. 12, pp. 2335–2348, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. R. S. Veazey, M. DeMaria, L. V. Chalifoux et al., “Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection,” Science, vol. 280, no. 5362, pp. 427–431, 1998. View at Publisher · View at Google Scholar · View at Scopus
  52. A. Prendergast, J. G. Prado, Y. H. Kang et al., “HIV-1 infection is characterized by profound depletion of CD161+ Th17 cells and gradual decline in regulatory T cells,” AIDS, vol. 24, no. 4, pp. 491–502, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. M. Salem, A. Ronit, J. C. Gaardbo et al., “Altered balance between IL-17A- and IL-17F-producing Th17 cells in HIV-infected patients,” Journal of Acquired Immune Deficiency Syndromes, vol. 63, pp. e28–e30, 2013. View at Google Scholar
  54. S. Dandekar, “Pathogenesis of HIV in the gastrointestinal tract,” Current HIV/AIDS Reports, vol. 4, no. 1, pp. 10–15, 2007. View at Publisher · View at Google Scholar · View at Scopus
  55. A. E. Hed, A. Khaitan, L. Kozhaya et al., “Susceptibility of human Th17 cells to human immunodeficiency virus and their perturbation during infection,” Journal of Infectious Diseases, vol. 201, no. 6, pp. 843–854, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. L. C. Ndhlovu, J. M. Chapman, A. R. Jha et al., “Suppression of HIV-1 plasma viral load below detection preserves IL-17 producing T cells in HIV-1 infection,” AIDS, vol. 22, no. 8, pp. 990–992, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. Y. Y. Feng, A. Merchant, C. M. Kovacs, M. Loutfy, D. Persad, and M. A. Ostrowski, “Virus-specific interleukin-17-producing CD4+ T cells are detectable in early human immunodeficiency virus type 1 infection,” Journal of Virology, vol. 82, no. 13, pp. 6767–6771, 2008. View at Publisher · View at Google Scholar · View at Scopus
  58. E. J. Ciccone, J. H. Greenwald, P. I. Lee et al., “CD4+ T cells, including Th17 and cycling subsets, are intact in the gut mucosa of HIV-1-infected long-term nonprogressors,” Journal of Virology, vol. 85, no. 12, pp. 5880–5888, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. J. C. Gaardbo, H. J. Hartling, K. Thorsteinsson, H. Ullum, and S. D. Nielsen, “CD3+CD8+CD161high Tc17 cells are depleted in HIV-infection,” AIDS, vol. 27, pp. 659–662, 2013. View at Google Scholar
  60. P. Nigam, S. Kwa, V. Velu, and R. R. Amara, “Loss of IL-17-producing CD8 T cells during late chronic stage of pathogenic simian immunodeficiency virus infection,” Journal of Immunology, vol. 186, no. 2, pp. 745–753, 2011. View at Publisher · View at Google Scholar · View at Scopus
  61. J. M. Brenchley, D. A. Price, T. W. Schacker et al., “Microbial translocation is a cause of systemic immune activation in chronic HIV infection,” Nature Medicine, vol. 12, no. 12, pp. 1365–1371, 2006. View at Publisher · View at Google Scholar · View at Scopus
  62. D. C. Douek, L. J. Picker, and R. A. Koup, “T cell dynamics in HIV-1 infection,” Annual Review of Immunology, vol. 21, pp. 265–304, 2003. View at Publisher · View at Google Scholar · View at Scopus
  63. D. C. Douek, M. Roederer, and R. A. Koup, “Emerging concepts in the immunopathogenesis of AIDS,” Annual Review of Medicine, vol. 60, pp. 471–484, 2009. View at Publisher · View at Google Scholar · View at Scopus
  64. V. Cecchinato, C. J. Trindade, A. Laurence et al., “Altered balance between Th17 and Th1 cells at mucosal sites predicts AIDS progression in simian immunodeficiency virus-infected macaques,” Mucosal Immunology, vol. 1, no. 4, pp. 279–288, 2008. View at Publisher · View at Google Scholar · View at Scopus
  65. M. Macal, S. Sankaran, T. W. Chun et al., “Effective CD4+ T-cell restoration in gut-associated lymphoid tissue of HIV-infected patients is associated with enhanced Th17 cells and polyfunctional HIV-specific T-cell responses,” Mucosal Immunology, vol. 1, no. 6, pp. 475–488, 2008. View at Publisher · View at Google Scholar · View at Scopus
  66. J. C. Gaardbo, H. J. Hartling, J. Gerstoft, and S. D. Nielsen, “Incomplete immune recovery in HIV infection: mechanisms, relevance for clinical care, and possible solutions,” Clinical and Developmental Immunology, vol. 2012, Article ID 670957, 17 pages, 2012. View at Publisher · View at Google Scholar
  67. Y. He, J. Li, Y. Zheng et al., “A randomized case-control study of dynamic changes in peripheral blood Th17/Treg cell balance and interleukin-17 levels in highly active antiretroviral-treated HIV type 1/AIDS patients,” AIDS Research and Human Retroviruses, vol. 28, pp. 339–345, 2012. View at Google Scholar
  68. L. Brandt, T. Benfield, H. Mens et al., “Low level of regulatory T cells and maintenance of balance between regulatory T cells and TH17 cells in HIV-1-infected elite controllers,” Journal of Acquired Immune Deficiency Syndromes, vol. 57, no. 2, pp. 101–108, 2011. View at Publisher · View at Google Scholar · View at Scopus
  69. A. Gosselin, P. Monteiro, N. Chomont et al., “Peripheral blood CCR4+CCR6+ and CXCR3+CCR6+CD4+ T cells are highly permissive to HIV-1 infection,” Journal of Immunology, vol. 184, no. 3, pp. 1604–1616, 2010. View at Publisher · View at Google Scholar · View at Scopus
  70. S. Cunningham-Rundles, S. Ahrne, R. Johann-Liang et al., “Effect of probiotic bacteria on microbial host defense, growth, and immune function in human immunodeficiency virus type-1 infection,” Nutrients, vol. 3, pp. 1042–1070, 2011. View at Google Scholar
  71. N. R. Klatt, N. T. Funderburg, and J. M. Brenchley, “Microbial translocation, immune activation, and HIV disease,” Trends in Microbiology, vol. 21, pp. 6–13, 2013. View at Google Scholar
  72. L. A. Gonzalez-Hernandez, L. F. Jave-Suarez, M. Fafutis-Morris et al., “Synbiotic therapy decreases microbial translocation and inflammation and improves immunological status in HIV-infected patients: a double-blind randomized controlled pilot trial,” Nutrition Journal, vol. 11, article 90, 2012. View at Google Scholar
  73. M. Schunter, H. Chu, T. L. Hayes et al., “Randomized pilot trial of a synbiotic dietary supplement in chronic HIV-1 infection,” BMC Complementary and Alternative Medicine, vol. 12, article 84, 2012. View at Google Scholar
  74. K. Hirota, B. Martin, and M. Veldhoen, “Development, regulation and functional capacities of Th17 cells,” Seminars in Immunopathology, vol. 32, no. 1, pp. 3–16, 2010. View at Publisher · View at Google Scholar · View at Scopus
  75. M. Veldhoen, K. Hirota, A. M. Westendorf et al., “The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins,” Nature, vol. 453, no. 7191, pp. 106–109, 2008. View at Publisher · View at Google Scholar · View at Scopus
  76. B. Stockinger and M. Veldhoen, “Differentiation and function of Th17 T cells,” Current Opinion in Immunology, vol. 19, no. 3, pp. 281–286, 2007. View at Publisher · View at Google Scholar · View at Scopus
  77. R. K. Benwell and D. R. Lee, “Essential and synergistic roles of IL1 and IL6 in human Th17 differentiation directed by TLR ligand-activated dendritic cells,” Clinical Immunology, vol. 134, no. 2, pp. 178–187, 2010. View at Publisher · View at Google Scholar · View at Scopus
  78. M. G. Kattah, M. T. Wong, M. D. Yocum, and P. J. Utz, “Cytokines secreted in response to toll-like receptor ligand stimulation modulate differentiation of human Th17 cells,” Arthritis and Rheumatism, vol. 58, no. 6, pp. 1619–1629, 2008. View at Publisher · View at Google Scholar · View at Scopus
  79. M. Fukata, K. Breglio, A. Chen et al., “The myeloid differentiation factor 88 (MyD88) is required for CD4+ T cell effector function in a murine model of inflammatory bowel disease,” Journal of Immunology, vol. 180, no. 3, pp. 1886–1894, 2008. View at Google Scholar · View at Scopus
  80. A. D. Reynolds, D. K. Stone, J. A. L. Hutter, E. J. Benner, R. L. Mosley, and H. E. Gendelman, “Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson's disease,” Journal of Immunology, vol. 184, no. 5, pp. 2261–2271, 2010. View at Publisher · View at Google Scholar · View at Scopus
  81. S. I. Gringhuis, J. den Dunnen, M. Litjens, M. van der Vlist, and T. B. H. Geijtenbeek, “Carbohydrate-specific signaling through the DC-SIGN signalosome tailors immunity to Mycobacterium tuberculosis, HIV-1 and Helicobacter pylori,” Nature Immunology, vol. 10, no. 10, pp. 1081–1088, 2009. View at Publisher · View at Google Scholar · View at Scopus
  82. S. I. Gringhuis, J. den Dunnen, M. Litjens, B. van het Hof, Y. van Kooyk, and T. H. Geijtenbeek, “C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappaB,” Immunity, vol. 26, no. 5, pp. 605–616, 2007. View at Publisher · View at Google Scholar · View at Scopus
  83. S. I. Gringhuis and T. B. H. Geijtenbeek, “Carbohydrate signaling by C-type lectin DC-SIGN affects NF-κB activity,” Methods in Enzymology, vol. 480, pp. 151–164, 2010. View at Publisher · View at Google Scholar · View at Scopus
  84. F. L. van de Veerdonk, R. J. Marijnissen, B. J. Kullberg et al., “The macrophage mannose receptor induces IL-17 in response to Candida albicans,” Cell Host and Microbe, vol. 5, no. 4, pp. 329–340, 2009. View at Publisher · View at Google Scholar · View at Scopus
  85. E. V. Acosta-Rodriguez, L. Rivino, J. Geginat et al., “Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells,” Nature Immunology, vol. 8, no. 6, pp. 639–646, 2007. View at Publisher · View at Google Scholar · View at Scopus
  86. N. Manel, D. Unutmaz, and D. R. Littman, “The differentiation of human TH-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγt,” Nature Immunology, vol. 9, no. 6, pp. 641–649, 2008. View at Publisher · View at Google Scholar · View at Scopus
  87. N. J. Wilson, K. Boniface, J. R. Chan et al., “Development, cytokine profile and function of human interleukin 17-producing helper T cells,” Nature Immunology, vol. 8, no. 9, pp. 950–957, 2007. View at Publisher · View at Google Scholar · View at Scopus
  88. L. Zhou, I. I. Ivanov, R. Spolski et al., “IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways,” Nature Immunology, vol. 8, no. 9, pp. 967–974, 2007. View at Publisher · View at Google Scholar · View at Scopus
  89. M. Nishihara, H. Ogura, N. Ueda et al., “IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state,” International Immunology, vol. 19, no. 6, pp. 695–702, 2007. View at Publisher · View at Google Scholar · View at Scopus
  90. M. Veldhoen, R. J. Hocking, C. J. Atkins, R. M. Locksley, and B. Stockinger, “TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells,” Immunity, vol. 24, no. 2, pp. 179–189, 2006. View at Publisher · View at Google Scholar · View at Scopus
  91. P. R. Mangan, L. E. Harrington, D. B. O'Quinn et al., “Transforming growth factor-β induces development of the T H17 lineage,” Nature, vol. 441, no. 7090, pp. 231–234, 2006. View at Publisher · View at Google Scholar · View at Scopus
  92. H. Qin, L. Wang, T. Feng et al., “TGF-β promotes Th17 cell development through inhibition of SOCS3,” Journal of Immunology, vol. 183, no. 1, pp. 97–105, 2009. View at Publisher · View at Google Scholar · View at Scopus
  93. R. Nurieva, X. O. Yang, Y. Chung, and C. Dong, “Cutting edge: in vitro generated Th17 cells maintain their cytokine expression program in normal but not lymphopenic hosts,” Journal of Immunology, vol. 182, no. 5, pp. 2565–2568, 2009. View at Publisher · View at Google Scholar · View at Scopus
  94. G. J. Martinez, R. I. Nurieva, X. O. Yang, and C. Dong, “Regulation and function of proinflammatory TH17 cells,” Annals of the New York Academy of Sciences, vol. 1143, pp. 188–211, 2008. View at Publisher · View at Google Scholar · View at Scopus
  95. M. A. Hoeve, N. D. L. Savage, T. de Boer et al., “Divergent effects of IL-12 and IL-23 on the production of IL-17 by human T cells,” European Journal of Immunology, vol. 36, no. 3, pp. 661–670, 2006. View at Publisher · View at Google Scholar · View at Scopus
  96. L. Wei, A. Laurence, K. M. Elias, and J. J. O'Shea, “IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner,” Journal of Biological Chemistry, vol. 282, no. 48, pp. 34605–34610, 2007. View at Publisher · View at Google Scholar · View at Scopus
  97. R. I. Nurieva and C. Dong, “Keeping autoimmunity in check: how to control a Th17 cell controller,” Immunity, vol. 29, no. 6, pp. 841–843, 2008. View at Publisher · View at Google Scholar · View at Scopus
  98. T. Korn, M. Mitsdoerffer, A. L. Croxford et al., “IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 47, pp. 18460–18465, 2008. View at Publisher · View at Google Scholar · View at Scopus
  99. F. Gerosa, B. Baldani-Guerra, L. A. Lyakh et al., “Differential regulation of interleukin 12 and interleukin 23 production in human dendritic cells,” Journal of Experimental Medicine, vol. 205, no. 6, pp. 1447–1461, 2008. View at Publisher · View at Google Scholar · View at Scopus
  100. C. Parham, M. Chirica, J. Timans et al., “A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rβ1 and a novel cytokine receptor subunit, IL-23R,” Journal of Immunology, vol. 168, no. 11, pp. 5699–5708, 2002. View at Google Scholar · View at Scopus
  101. S. Aggarwal, N. Ghilardi, M. H. Xie, F. J. De Sauvage, and A. L. Gurney, “Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17,” Journal of Biological Chemistry, vol. 278, no. 3, pp. 1910–1914, 2003. View at Publisher · View at Google Scholar · View at Scopus
  102. D. Emilie, M. Peuchmaur, M. C. Maillot et al., “Production of interleukins in human immunodeficiency virus-1-replicating lymph nodes,” Journal of Clinical Investigation, vol. 86, no. 1, pp. 148–159, 1990. View at Google Scholar · View at Scopus
  103. D. L. Birx, R. R. Redfield, K. Tencer, A. Fowler, D. S. Burke, and G. I. Tosato, “Induction of interleukin-6 during human immunodeficiency virus infection,” Blood, vol. 76, no. 11, pp. 2303–2310, 1990. View at Google Scholar · View at Scopus
  104. T. P. Stein, B. Koerner, M. D. Schluter et al., “Weight loss, the gut and the inflammatory response in AIDS patients,” Cytokine, vol. 9, no. 2, pp. 143–147, 1997. View at Publisher · View at Google Scholar · View at Scopus
  105. A. Iannello, M. R. Boulassel, S. Samarani et al., “Dynamics and consequences of IL-21 production in HIV-infected individuals: a longitudinal and cross-sectional study,” Journal of Immunology, vol. 184, no. 1, pp. 114–126, 2010. View at Publisher · View at Google Scholar · View at Scopus
  106. A. Iannello, C. Tremblay, J. P. Routy, M. R. Boulassel, E. Toma, and A. Ahmad, “Decreased levels of circulating IL-21 in HIV-infected AIDS patients: correlation with CD4+ T-cell counts,” Viral Immunology, vol. 21, no. 3, pp. 385–388, 2008. View at Publisher · View at Google Scholar · View at Scopus
  107. L. Micci, B. Cervasi, Z. S. Ende et al., “Paucity of IL-21-producing CD4+ T cells is associated with Th17 cell depletion in SIV infection of rhesus macaques,” Blood, vol. 120, pp. 3925–3935, 2012. View at Google Scholar
  108. S. Pallikkuth, A. Parmigiani, and S. Pahwa, “Role of IL-21 and IL-21 receptor on B cells in HIV infection,” Critical Reviews in Immunology, vol. 32, pp. 173–195, 2012. View at Google Scholar
  109. S. Pallikkuth, S. P. Kanthikeel, S. Y. Silva, M. Fischl, R. Pahwa, and S. Pahwa, “Upregulation of IL-21 receptor on B cells and IL-21 secretion distinguishes novel 2009 H1N1 vaccine responders from nonresponders among HIV-infected persons on combination antiretroviral therapy,” Journal of Immunology, vol. 186, no. 11, pp. 6173–6181, 2011. View at Publisher · View at Google Scholar · View at Scopus
  110. N. Strbo, L. De Armas, H. Liu, M. A. Kolber, M. Lichtenheld, and S. Pahwa, “IL-21 augments natural killer effector functions in chronically HIV-infected individuals,” AIDS, vol. 22, no. 13, pp. 1551–1560, 2008. View at Publisher · View at Google Scholar · View at Scopus
  111. L. White, S. Krishnan, N. Strbo et al., “Differential effects of IL-21 and IL-15 on perforin expression, lysosomal degranulation, and proliferation in CD8 T cells of patients with human immunodeficiency virus-1 (HIV),” Blood, vol. 109, no. 9, pp. 3873–3880, 2007. View at Publisher · View at Google Scholar · View at Scopus
  112. D. Favre, S. Lederer, B. Kanwar et al., “Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection,” PLoS Pathogens, vol. 5, no. 2, Article ID e1000295, 2009. View at Publisher · View at Google Scholar · View at Scopus
  113. D. Favre, J. Mold, P. W. Hunt et al., “Tryptophan catabolism by indoleamine 2, 3-dioxygenase 1 alters the balance of TH17 to regulatory T cells in HIV disease,” Science Translational Medicine, vol. 2, no. 32, p. 32, 2010. View at Publisher · View at Google Scholar · View at Scopus
  114. D. J. Hartigan-O'Connor, K. Abel, and J. M. McCune, “Suppression of SIV-specific CD4+ T cells by infant but not adult macaque regulatory T cells: implications for SIV disease progression,” Journal of Experimental Medicine, vol. 204, no. 11, pp. 2679–2692, 2007. View at Publisher · View at Google Scholar · View at Scopus
  115. R. K. Reeves, P. A. Rajakumar, T. I. Evans et al., “Gut inflammation and indoleamine deoxygenase inhibit IL-17 production and promote cytotoxic potential in NKp44+ mucosal NK cells during SIV infection,” Blood, vol. 118, pp. 3321–3330, 2011. View at Google Scholar
  116. J. C. Gaardbo, S. D. Nielsen, S. J. Vedel et al., “Regulatory T cells in human immunodeficiency virus-infected patients are elevated and independent of immunological and virological status, as well as initiation of highly active anti-retroviral therapy,” Clinical and Experimental Immunology, vol. 154, no. 1, pp. 80–86, 2008. View at Publisher · View at Google Scholar · View at Scopus
  117. L. Kolte, J. C. Gaardbo, K. Skogstrand, L. P. Ryder, A. K. Ersbøll, and S. D. Nielsen, “Increased levels of regulatory T cells (Tregs) in human immunodeficiency virus-infected patients after 5 years of highly active anti-retroviral therapy may be due to increased thymic production of naive Tregs,” Clinical and Experimental Immunology, vol. 155, no. 1, pp. 44–52, 2009. View at Publisher · View at Google Scholar · View at Scopus
  118. A. Lim, D. Tan, P. Price et al., “Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy,” AIDS, vol. 21, no. 12, pp. 1525–1534, 2007. View at Publisher · View at Google Scholar · View at Scopus
  119. S. Tsunemi, T. Iwasaki, T. Imado et al., “Relationship of CD4+CD25+ regulatory T cells to immune status in HIV-infected patients,” AIDS, vol. 19, no. 9, pp. 879–886, 2005. View at Google Scholar · View at Scopus
  120. J. Schulze Zur Wiesch, A. Thomssen, P. Hartjen et al., “Comprehensive analysis of frequency and phenotype of T regulatory cells in HIV infection: CD39 expression of FoxP3+ T regulatory cells correlates with progressive disease,” Journal of Virology, vol. 85, no. 3, pp. 1287–1297, 2011. View at Publisher · View at Google Scholar · View at Scopus
  121. I. I. Ivanov, B. S. McKenzie, L. Zhou et al., “The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells,” Cell, vol. 126, no. 6, pp. 1121–1133, 2006. View at Publisher · View at Google Scholar · View at Scopus
  122. R. Nurieva, X. O. Yang, G. Martinez et al., “Essential autocrine regulation by IL-21 in the generation of inflammatory T cells,” Nature, vol. 448, no. 7152, pp. 480–483, 2007. View at Publisher · View at Google Scholar · View at Scopus
  123. X. O. Yang, A. D. Panopoulos, R. Nurieva et al., “STAT3 regulates cytokine-mediated generation of inflammatory helper T cells,” Journal of Biological Chemistry, vol. 282, no. 13, pp. 9358–9363, 2007. View at Publisher · View at Google Scholar · View at Scopus
  124. X. O. Yang, B. P. Pappu, R. Nurieva et al., “T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma,” Immunity, vol. 28, no. 1, pp. 29–39, 2008. View at Publisher · View at Google Scholar · View at Scopus
  125. C. M. Rueda, P. A. Velilla, C. A. Chougnet, C. J. Montoya, and M. T. Rugeles, “HIV-induced T-cell activation/exhaustion in rectal mucosa is controlled only partially by antiretroviral treatment,” PLoS One, vol. 7, Article ID e30307, 2012. View at Google Scholar
  126. K. Hirahara, K. Ghoreschi, A. Laurence, X. P. Yang, Y. Kanno, and J. J. O'Shea, “Signal transduction pathways and transcriptional regulation in Th17 cell differentiation,” Cytokine and Growth Factor Reviews, vol. 21, no. 6, pp. 425–434, 2010. View at Publisher · View at Google Scholar · View at Scopus
  127. J. J. O'Shea, S. M. Steward-Tharp, A. Laurence et al., “Signal transduction and Th17 cell differentiation,” Microbes and Infection, vol. 11, no. 5, pp. 599–611, 2009. View at Publisher · View at Google Scholar · View at Scopus
  128. T. J. Harris, J. F. Grosso, H. R. Yen et al., “An in vivo requirement for STAT3 signaling in TH17 development and TH17-dependent autoimmunity,” Journal of Immunology, vol. 179, no. 7, pp. 4313–4317, 2007. View at Google Scholar · View at Scopus
  129. Z. Chen, A. Laurence, Y. Kanno et al., “Selective regulatory function of Socs3 in the formation of IL-17-secreting T cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 21, pp. 8137–8142, 2006. View at Publisher · View at Google Scholar · View at Scopus
  130. R. C. Miller, E. Schlaepfer, S. Baenziger et al., “HIV interferes with SOCS-1 and -3 expression levels driving immune activation,” European Journal of Immunology, vol. 41, no. 4, pp. 1058–1069, 2011. View at Publisher · View at Google Scholar · View at Scopus
  131. M. Mohan, P. P. Aye, J. T. Borda, X. Alvarez, and A. A. Lackner, “CCAAT/enhancer binding protein β is a major mediator of inflammation and viral replication in the gastrointestinal tract of simian immunodeficiency virus-infected rhesus macaques,” American Journal of Pathology, vol. 173, no. 1, pp. 106–118, 2008. View at Publisher · View at Google Scholar · View at Scopus
  132. L. N. Akhtar, H. Qin, M. T. Muldowney et al., “Suppressor of cytokine signaling 3 inhibits antiviral IFN-β signaling to enhance HIV-1 replication in macrophages,” Journal of Immunology, vol. 185, no. 4, pp. 2393–2404, 2010. View at Publisher · View at Google Scholar · View at Scopus
  133. K. A. Kim, W. Lin, A. W. Tai et al., “Hepatic SOCS3 expression is strongly associated with non-response to therapy and race in HCV and HCV/HIV infection,” Journal of Hepatology, vol. 50, no. 4, pp. 705–711, 2009. View at Publisher · View at Google Scholar · View at Scopus
  134. N. M. Moutsopoulos, N. Vázquez, T. Greenwell-Wild et al., “Regulation of the tonsil cytokine milieu favors HIV susceptibility,” Journal of Leukocyte Biology, vol. 80, no. 5, pp. 1145–1155, 2006. View at Publisher · View at Google Scholar · View at Scopus
  135. C. D. Chung, J. Liao, B. Liu et al., “Specific inhibition of Stat3 signal transduction by PIAS3,” Science, vol. 278, no. 5344, pp. 1803–1805, 1997. View at Publisher · View at Google Scholar · View at Scopus
  136. Z. Yagil, H. Nechushtan, G. Kay, C. M. Yang, D. M. Kemeny, and E. Razin, “The enigma of the role of Protein inhibitor of Activated STAT3 (PIAS3) in the immune response,” Trends in Immunology, vol. 31, no. 5, pp. 199–204, 2010. View at Publisher · View at Google Scholar · View at Scopus
  137. C. Borghouts, H. Tittmann, N. Delis, M. Kirchenbauer, B. Brill, and B. Groner, “The intracellular delivery of a recombinant peptide derived from the acidic domain of PIAS3 inhibits STAT3 transactivation and induces tumor cell death,” Molecular Cancer Research, vol. 8, no. 4, pp. 539–553, 2010. View at Publisher · View at Google Scholar · View at Scopus
  138. M. P. Mycko, M. Cichalewska, A. Machlanska, H. Cwiklinska, M. Mariasiewicz, and K. W. Selmaj, “MicroRNA-301a regulation of a T-helper 17 immune response controls autoimmune demyelination,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, pp. E1248–E1257, 2012. View at Google Scholar
  139. S. L. Bixler, N. G. Sandler, D. C. Douek, and J. J. Mattapallil, “Suppressed Th17 levels correlate with elevated PIAS3, SHP2, and SOCS3 expression in CD4 T cells during acute simian immunodeficiency virus infection,” Journal of virology. In press.
  140. H. Kim, T. S. Hawley, R. G. Hawley, and H. Baumann, “Protein tyrosine phosphatase 2 (SHP-2) moderates signaling by gp130 but is not required for the induction of acute-phase plasma protein genes in hepatic cells,” Molecular and Cellular Biology, vol. 18, no. 3, pp. 1525–1533, 1998. View at Google Scholar · View at Scopus
  141. T. Ohtani, K. Ishihara, T. Atsumi et al., “Dissection of signaling cascades through gp130 in vivo: reciprocal roles for STAT3- and SHP2-mediated signals in immune responses,” Immunity, vol. 12, no. 1, pp. 95–105, 2000. View at Google Scholar · View at Scopus
  142. A. Balasubramanian, R. K. Ganju, and J. E. Groopman, “Hepatitis C virus and HIV envelope proteins collaboratively mediate interleukin-8 secretion through activation of p38 MAP kinase and SHP2 in hepatocytes,” Journal of Biological Chemistry, vol. 278, no. 37, pp. 35755–35766, 2003. View at Publisher · View at Google Scholar · View at Scopus